Latest News

No Results Found

Try adjusting your search to find what you’re looking for.


Cancer Screening and the Path Forward

A recent meta-analysis published in JAMA Internal Medicine (August 2023) found no evidence that the most common types of cancer screening are providing statistically significant benefits in overall survival, with the exception of colorectal cancer screening with sigmoidoscopy. How can this be?

Read More

Illumina Ventures Announces New Partner, Mara Aspinall, Has Joined Its Investment Team

Illumina Ventures today announced that Mara Aspinall, MBA, has joined the Company’s investment team as a Partner.   

Read More

Company Spotlight – DELFI Diagnostics

DELFI Diagnostics is developing a new generation of liquid biopsies that could advance these applications. Built on a new method called fragmentomics and amplified by machine learning, DELFI’s approach is already showing promise, providing early detection for lung, liver and other cancers, and could provide essential insights to inform precision medicine.

Read More

Illumina Ventures to Launch Illumina® Ventures Labs

Illumina Ventures, a leading genomics and precision health venture firm, today announced plans to launch Illumina® Ventures Labs.

Read More